We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Epigenetic Similarity in Cancer Cells Characterizes More Aggressive Tumors

By LabMedica International staff writers
Posted on 29 Aug 2016
Print article
Image: A microscopic view of a colon cancer section (Photo courtesy of IDIBELL-Bellvitge Biomedical Research Institute).
Image: A microscopic view of a colon cancer section (Photo courtesy of IDIBELL-Bellvitge Biomedical Research Institute).
Cancer researchers have found that the degree of epigenetic similarity among colorectal tumor cells was reflected in patients as significantly shortened relapse-free survival time and shortened time of overall survival.

Few biomarkers for predicting outcomes of patients with colorectal cancer have been validated. This is in part due to the genetic and molecular heterogeneity of colorectal tumors not only among different patients, but also within the tumors themselves.

To better understand the puzzle of tumor cell heterogeneity, investigators at IDIBELL-Bellvitge Biomedical Research Institute (Barcelona, Spain) analyzed DNA methylation profiles of the digestive tract surface and the central bulk and invasive front regions of 79 colorectal tumors and 23 associated liver metastases, obtained from two hospitals in Spain. They also analyzed samples for KRAS and BRAF mutations, 499,170 single nucleotide polymorphisms, and performed immunohistochemical analyses.

Results showed that among three defined tumor sections, differences in DNA methylation were most pronounced at the site of the tumor-host interface. Tumor samples collected from areas closer to the gastrointestinal transit most frequently shared methylation events with metastases. When individual coefficients were calculated to quantify heterogeneity, epigenetic homogeneity was found to be significantly associated with short time of relapse-free survival and short time of overall survival.

"In patients with colorectal cancer, we determined the epigenome of three regions of each individual tumor. The area looking at the beginning of the digestive tract, central and growing into the blood vessels results demonstrate the existence of intratumoral heterogeneity, which means that each region has differences," said senior author Dr. Manel Esteller, director of the epigenetics and cancer biology program at Bellvitge Biomedical Research Institute. "The more epigenetically different region is the invasive front, the area that interacts with adjacent normal tissues. We have also seen that the intratumoral region most similar to metastatic stages is the oldest of the tumor, which suggests spreading even in apparently early stages. Furthermore, data show that the more similar the three regions are, the more aggressive the tumor is, just as if the cell population with more proliferation capacity had already been selected. Measurements of the level of molecular heterogeneity of tumors could then be used as predictors of their prognosis and potential to acquire resistance to therapies."

The study was published in the August 10, 2016, online edition of the journal Gastroenterology.

Related Links:
IDIBELL-Bellvitge Biomedical Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.